Stock Events

Stock Events

Corvus Pharmaceuticals (C17.F) Q2 2024 Earnings

6MayConfirmed

Q1 2023

Q2 2023

Q3 2023

Q2 2024

-0.13

-0.12

-0.12

-0.11

Details

Expected EPS

-0.1253475

Actual EPS

-0.11141999999999999

Surprise EPS

0.01

Surprise Percent

+11.11%

Description

Corvus Pharmaceuticals (C17.F) has reported earnings of -0.11141999999999999 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.